Evidence map›Paper›PMID 33106209›Full record

ArticleOncology research2021

Identification of a Novel Cancer Stemness-Associated ceRNA Axis in Lung Adenocarcinoma via Stemness Indices Analysis.

Pihua Han, Haiming Yang, Xiang Li, Jie Wu, Peili Wang, Dapeng Liu, Guodong Xiao, Xin Sun, Hong Ren

Abstract read
In one paragraph

Article in Oncology research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. A review on the role of miR-671 in human disorders.Frontiers in molecular biosciences · 2022
    Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pihua HanThe Second Department of Thoracic Surgery, Cancer Center, the First Affiliated Hospital of Xian Jiaotong UniversityXianP.R. China.
Haiming YangDepartment of Breast Surgery, Wei Nan Central HospitalWei NanP.R. China.
Xiang LiThe Second Department of Thoracic Surgery, Cancer Center, the First Affiliated Hospital of Xian Jiaotong UniversityXianP.R. China.
Jie WuThe Second Department of Thoracic Surgery, Cancer Center, the First Affiliated Hospital of Xian Jiaotong UniversityXianP.R. China.
Peili WangBreast Cancer Center, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer HospitalZhengzhouP.R. China.
Dapeng LiuThe Second Department of Thoracic Surgery, Cancer Center, the First Affiliated Hospital of Xian Jiaotong UniversityXianP.R. China.
Guodong XiaoDepartment of Oncology, the First Affiliated Hospital of Zhengzhou UniversityZhengzhouP.R. China.
Xin SunThe Second Department of Thoracic Surgery, Cancer Center, the First Affiliated Hospital of Xian Jiaotong UniversityXianP.R. China.
Hong RenThe Second Department of Thoracic Surgery, Cancer Center, the First Affiliated Hospital of Xian Jiaotong UniversityXianP.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to identify a novel cancer stemness-related ceRNA regulatory axis in lung adenocarcinoma (LUAD) via weighted gene coexpression network analysis of a stemness index. The RNA sequencing expression profiles of 513 cancer samples and 60 normal samples were obtained from the TCGA database. Differentially expressed mRNAs (DEmRNAs), lncRNAs (DElncRNAs), and miRNAs (DEmiRNAs) were identified with R software. Functional enrichment analysis was conducted using DAVID 6.8. The ceRNA network was constructed via multiple bioinformatics analyses, and the correlations between possible ceRNAs and prognosis were analyzed using KaplanMeier plots. WGCNA was then applied to distinguish key genes related to the mRNA expression-based stemness index (mRNAsi) in LUAD. After combining the weighted gene coexpression and ceRNA networks, a novel ceRNA regulatory axis was identified, and its biological functions were explored in vitro and vivo. In total, 1,825 DElncRNAs, 291 DEmiRNAs, and 3,742 DEmRNAs were identified. Functional enrichment analysis revealed that the DEmRNAs might be associated with LUAD onset and progression. The ceRNA network was constructed with 14 lncRNAs, 10 miRNAs, and 52 mRNAs. KaplanMeier analysis identified 2 DEmiRNAs, 5 DElncRNAs, and 41 DEmRNAs with remarkable prognostic power. One gene (MFAP4) in the ceRNA network was found to be closely related to mRNAsi by using WGCNA. Functional investigation further confirmed that the C8orf34-as1/miR-671-5p/MFAP4 regulatory axis has important functions in LUAD cell migration and stemness. This study provides a deeper understanding of the lncRNAmiRNAmRNA ceRNA network and, more importantly, reveals a novel ceRNA regulatory axis, which may provide new insights into novel molecular therapeutic targets for inhibiting LUAD stem characteristics.

Indexed as

A549 CellsAdenocarcinoma of LungAgedAnimalsBiomarkers, TumorCarrier ProteinsComputational BiologyExtracellular Matrix ProteinsFemaleGene Expression Regulation, NeoplasticGene Regulatory NetworksGlycoproteinsHumansKaplan-Meier EstimateLung NeoplasmsMaleBiomarkers, TumorCarrier ProteinsExtracellular Matrix ProteinsGlycoproteinsMFAP4 protein, humanMicroRNAsRNA, Long NoncodingRNA, Messenger

Identifiers

PMID33106209
PMCPMC8420898

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.